Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose and glycogen dynamics in prediabetes with optional acipimox intervention
NL-OMON53214Recruiting
- Sponsor
- Maastricht University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of acipimox in prediabetes (4 arms), sponsored by Maastricht University. Primary endpoints: Liver and muscle glycogen, Whole body gluconeogenesis and 1 more. Started Feb 2024; status: recruiting.
02
Drugs
acipimox
03
Conditions
prediabetes
Beyond the preview
Go deeper on NL-OMON53214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53214.